Advanced search
Publication Cover
International Journal of General Medicine Volume 13, 2020 - Issue
Submit an article Journal homepage
213
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Clinical Benefits of Piperacillin/Tazobactam versus a Combination of Ceftriaxone and Clindamycin in the Treatment of Early, Non-Ventilator, Hospital-Acquired Pneumonia in a Community-Based Hospital

Ga Eun Park1 Division of Infectious Disease, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea
,
Jae-Hoon Ko2 Division of Infectious Diseases, Department of Internal Medicine, Samsung Medical Center, Seoul, Korea
&
Hyun Kyun Ki1 Division of Infectious Disease, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, KoreaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8391-6513
ORCID Icon
Pages 705-712 | Published online: 24 Sep 2020

References

  • Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of america and the american thoracic society. Clinical Infectious Diseases. 2016;63(5):e61e111.27418577
  • Magill SS, Edwards JR, Bamberg W, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370(13):1198–1208. doi:10.1056/NEJMoa130680124670166
  • Chawla R. Epidemiology, etiology, and diagnosis of hospital-acquired pneumonia and ventilator-associated pneumonia in Asian countries. Am J Infect Control. 2008;36(4 Suppl):S93100. doi:10.1016/j.ajic.2007.05.011
  • Eber MR, Laxminarayan R, Perencevich EN, Malani A. Clinical and economic outcomes attributable to health care-associated sepsis and pneumonia. Arch Intern Med. 2010;170(4):347–353. doi:10.1001/archinternmed.2009.50920177037
  • Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995. Am J Respir Crit Care Med. 1996;153(5):1711–1725. doi:10.1164/ajrccm.153.5.86306268630626
  • Song JH. Treatment recommendations of hospital-acquired pneumonia in Asian countries: first consensus report by the Asian HAP Working Group. Am J Infect Control. 2008;36(4 Suppl):S8392. doi:10.1016/j.ajic.2007.01.015
  • Montravers P, Harpan A, Guivarch E. Current and future considerations for the treatment of hospital-acquired Pneumonia. Adv Ther. 2016;33(2):151–166. doi:10.1007/s12325-016-0293-x26861846
  • Torres A, Ewig S, Lode H, Carlet J. Defining, treating and preventing hospital acquired pneumonia: european perspective. Intensive Care Med. 2009;35(1):9–29. doi:10.1007/s00134-008-1336-918989656
  • Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–682. doi:10.1093/aje/kwq43321330339
  • Rotstein C, Evans G, Born A, et al. Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults. Canadian J Infectious Diseases Med Microbiol. 2008;19(1):19–53. doi:10.1155/2008/593289
  • Napolitano LM. Use of severity scoring and stratification factors in clinical trials of hospital-acquired and ventilator-associated pneumonia. Clinical Infectious Diseases. 2010;51(Suppl 1):S6780. doi:10.1086/653052
  • Carrabba M, Zarantonello M, Bonara P, et al. Severity assessment of healthcare-associated pneumonia and pneumonia in immunosuppression. Eur Respir J. 2012;40(5):1201–1210. doi:10.1183/09031936.0018781122408203
  • Chung DR, Song JH, Kim SH, et al. High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia. Am J Respir Crit Care Med. 2011;184(12):1409–1417. doi:10.1164/rccm.201102-0349OC21920919
  • Davis J, Finley E. The breadth of hospital-acquired pneumonia: nonventilated versus ventilated patients in Pennsylvania. 2012.
  • Giuliano KK, Baker D, Quinn B. The epidemiology of nonventilator hospital-acquired pneumonia in the United States. Am J Infect Control. 2017.
  • Naidus EL, Lasalvia MT, Marcantonio ER, Herzig SJ. The diagnostic yield of noninvasive microbiologic sputum sampling in a cohort of patients with clinically diagnosed hospital-acquired Pneumonia. J Hospital Med. 2018;13(1):34–37. doi:10.12788/jhm.2868
  • Hecht DW. Prevalence of antibiotic resistance in anaerobic bacteria: worrisome developments. Clinical Infectious Diseases. 2004;39(1):92–97. doi:10.1086/42155815206059
  • Lee Y, Park YJ, Kim MN, Uh Y, Kim MS, Lee K. Multicenter study of antimicrobial susceptibility of anaerobic bacteria in Korea in 2012. Ann Lab Med. 2015;35(5):479–486. doi:10.3343/alm.2015.35.5.47926206683
  • Bartlett JG. How important are anaerobic bacteria in aspiration pneumonia: when should they be treated and what is optimal therapy. Infect Dis Clin North Am. 2013;27(1):149–155. doi:10.1016/j.idc.2012.11.01623398871
  • Maruyama T, Fujisawa T, Ishida T, et al. A therapeutic strategy for all pneumonia patients: a 3-year prospective multicenter- cohort study using risk factors for multidrug resistant pathogens to select initial empiric therapy. Clinical Infectious Diseases. 2018.
  • Sopena N, Sabria M. Multicenter study of hospital-acquired pneumonia in non-ICU patients. Chest. 2005;127(1):213–219. doi:10.1378/chest.127.1.21315653986

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.